Filing Details
- Accession Number:
- 0001214659-17-005694
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-20 19:14:18
- Reporting Period:
- 2017-09-20
- Accepted Time:
- 2017-09-20 19:14:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1316175 | Anthera Pharmaceuticals Inc | ANTH | Pharmaceutical Preparations (2834) | 201852016 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509643 | Craig John Thompson | 25801 Industrial Blvd Suite B Hayward CA 94545 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-20 | 8,550 | $1.32 | 19,848 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person acquired the shares in the open market at a cost of $1.32 per share.
Billionaire Hedge Funds
